The mitochondrial protease ClpP is a novel target for the treatment of multiple myeloma
The team of researchers led by Professor Simone Cenci and Dr. Matteo Bellone at IRCCS Ospedale San Raffaele has identified the mitochondrial protease ClpP as a novel potential target for the treatment of multiple myeloma (MM). The results of the work have been published in this week’s issue of the journal Blood.
MORE